AT353957B - Verfahren zur herstellung von neuen cephalos- porinderivaten - Google Patents

Verfahren zur herstellung von neuen cephalos- porinderivaten

Info

Publication number
AT353957B
AT353957B AT807276A AT807276A AT353957B AT 353957 B AT353957 B AT 353957B AT 807276 A AT807276 A AT 807276A AT 807276 A AT807276 A AT 807276A AT 353957 B AT353957 B AT 353957B
Authority
AT
Austria
Prior art keywords
cephalos
producing new
porin
derivatives
porin derivatives
Prior art date
Application number
AT807276A
Other languages
German (de)
English (en)
Other versions
ATA807276A (de
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/704,142 external-priority patent/US4118491A/en
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of ATA807276A publication Critical patent/ATA807276A/de
Application granted granted Critical
Publication of AT353957B publication Critical patent/AT353957B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT807276A 1975-10-30 1976-10-29 Verfahren zur herstellung von neuen cephalos- porinderivaten AT353957B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62716475A 1975-10-30 1975-10-30
US66583776A 1976-03-11 1976-03-11
US05/704,142 US4118491A (en) 1976-03-11 1976-07-12 7-Acyl-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them

Publications (2)

Publication Number Publication Date
ATA807276A ATA807276A (de) 1979-05-15
AT353957B true AT353957B (de) 1979-12-10

Family

ID=27417417

Family Applications (1)

Application Number Title Priority Date Filing Date
AT807276A AT353957B (de) 1975-10-30 1976-10-29 Verfahren zur herstellung von neuen cephalos- porinderivaten

Country Status (17)

Country Link
JP (1) JPS6053026B2 (xx)
AT (1) AT353957B (xx)
AU (1) AU505141B2 (xx)
CA (1) CA1071188A (xx)
CH (1) CH627757A5 (xx)
DE (1) DE2649545A1 (xx)
DK (1) DK463176A (xx)
ES (1) ES452769A1 (xx)
FI (1) FI60868C (xx)
FR (3) FR2361896A1 (xx)
GB (3) GB1570093A (xx)
GR (1) GR61667B (xx)
IE (1) IE44393B1 (xx)
IL (3) IL50546A (xx)
LU (1) LU76092A1 (xx)
NL (1) NL7612010A (xx)
SE (3) SE435291B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117123A (en) * 1977-06-09 1978-09-26 Smithkline Corporation 7-Acylamino-3-[1-(2-sulfamidoethyl)tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
AT383811B (de) * 1983-09-22 1987-08-25 Biochemie Gmbh Verfahren zur herstellung von monoalkalisalzen von 7-amino-3-cephem-4-carbonsaeurederivaten
US4717531A (en) * 1983-09-23 1988-01-05 Westinghouse Electric Corp. Fuel transfer system upender using translation drive

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207752A1 (es) * 1973-03-30 1976-10-29 Fujisawa Pharmaceutical Co Procedimiento para obtener acidos 7-amino-sustituido-3-tiometilsustituido-3-cefem-4-carboxilicos
NL7414119A (nl) * 1973-10-31 1975-05-02 Fujisawa Pharmaceutical Co Werkwijze ter bereiding van 1h-tetrazool-5-thiol- derivaten en 1-gesubstitueerde 1h-tetrazool- -5-thiolen.
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid

Also Published As

Publication number Publication date
FR2351982B1 (xx) 1981-07-03
JPS5257191A (en) 1977-05-11
CH627757A5 (en) 1982-01-29
DE2649545A1 (de) 1977-05-12
AU1870276A (en) 1978-04-20
IL56757A0 (en) 1979-05-31
NL7612010A (nl) 1977-05-03
FI60868C (fi) 1982-04-13
LU76092A1 (xx) 1977-05-17
GB1570095A (en) 1980-06-25
FR2337720B1 (xx) 1981-07-10
IL56758A0 (en) 1979-05-31
FR2361896B1 (xx) 1979-02-23
FI60868B (fi) 1981-12-31
GB1570094A (en) 1980-06-25
GB1570093A (en) 1980-06-25
FR2337720A1 (fr) 1977-08-05
IL50546A (en) 1980-07-31
FR2351982A1 (fr) 1977-12-16
GR61667B (en) 1978-12-05
CA1071188A (en) 1980-02-05
ATA807276A (de) 1979-05-15
SE435291B (sv) 1984-09-17
SE8006414L (sv) 1980-09-12
IE44393B1 (en) 1981-11-18
JPS6053026B2 (ja) 1985-11-22
SE7610722L (sv) 1977-05-01
SE437025B (sv) 1985-02-04
IL50546A0 (en) 1976-11-30
DK463176A (da) 1977-05-01
SE452621B (sv) 1987-12-07
AU505141B2 (en) 1979-11-08
ES452769A1 (es) 1978-01-16
FI763044A (xx) 1977-05-01
SE8006413L (sv) 1980-09-12
FR2361896A1 (fr) 1978-03-17
IE44393L (en) 1977-09-11

Similar Documents

Publication Publication Date Title
AT351164B (de) Verfahren zur herstellung von neuen cephalos- porinderivaten
AT353783B (de) Verfahren zur herstellung von neuen pyrrolidin- -2-on-derivaten
AT360005B (de) Verfahren zur herstellung von neuen sulfonyl- benzimidazolderivaten
AT362085B (de) Verfahren zur herstellung von neuen 16- -dehydroandrostan-derivaten
AT344163B (de) Verfahren zur herstellung von neuen oxadiazolinon-derivaten
AT360006B (de) Verfahren zur herstellung von neuen thiazolinylbenzimidazolderivaten
AT347453B (de) Verfahren zur herstellung von neuen 5-phenyl- oxazolidinon-2-derivaten
AT350197B (de) Verfahren zur herstellung von neuen ebur- nameninderivaten
ATA145077A (de) Verfahren zur herstellung von neuen ergolen- -derivaten
ATA9375A (de) Verfahren zur herstellung von neuen naphthalinderivaten
AT354650B (de) Verfahren zur herstellung von neuen bicyclo- heptenderivaten
AT352298B (de) Verfahren zur herstellung von neuen vincan- derivaten
AT353957B (de) Verfahren zur herstellung von neuen cephalos- porinderivaten
AT353278B (de) Verfahren zur herstellung von neuen azetidin- derivaten
AT344725B (de) Verfahren zur herstellung von neuen bis-isothiuronium-salzen
ATA504978A (de) Verfahren zur herstellung von neuen thienothiazinderivaten
ATA504878A (de) Verfahren zur herstellung von neuen thienothiazinderivaten
ATA505178A (de) Verfahren zur herstellung von neuen thieno- thiazinderivaten
ATA893377A (de) Verfahren zur herstellung von neuen thieno- thiazinderivaten
AT346354B (de) Verfahren zur herstellung von neuen 2- morpholinonderivaten
ATA649277A (de) Verfahren zur herstellung von neuen benzhydrylsulfinylalkylamidinen
AT346355B (de) Verfahren zur herstellung von neuen 2- morpholinonderivaten
ATA127476A (de) Verfahren zur herstellung von neuen cephemderivaten
AT350563B (de) Verfahren zur herstellung von neuen triazol- derivaten
AT348511B (de) Verfahren zur herstellung von neuen tetralinderivaten

Legal Events

Date Code Title Description
EFA Change in the company name
ELJ Ceased due to non-payment of the annual fee